An observational study in Hallux Valgus and Surgery, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-25.
Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational
Among 17 studies in Hallux Valgus with a site in France — 3 open to participants now, 5 under way, none of them phase 3. Hallux Valgus · France.
Among the 17 studies in Hallux Valgus with a site in France, this one is one of 3 that started in 2022, is one of 4 observational ones, and was the 12th registered.
157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.
Browse Hallux Valgus studies →3 of the 17 studies in Hallux Valgus with a site in France are open now. Recruiting first, the newest first:
Clinique Saint Jean, France · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
GCS Ramsay Santé pour l'Enseignement et la Recherche · Sites in France
Ages 18–85
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 21 Hallux Valgus studies recruiting now, 10 (48%) set no upper age limit and 7 (33%) stop at 75 or younger; 3 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2022.
This study's enrollment of 71 is above the median of 60 across 35 observational studies indexed under Hallux Valgus.
Median enrollment 74 across the 13 interventional studies, 76 across the 4 observational. Of the 12 that completed or were terminated, 2 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 17 have an industry lead sponsor. The 10 most frequent:
GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 207 studies on the registry; 99 are open to participants now.
GCS Ramsay Santé pour l'Enseignement et la Recherche has 3 studies filed under Hallux Valgus — fewer than ten, so there is no comparison to draw.
2 of the studies in Hallux Valgus with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06680518Clinique Saint Jean, FranceTourniquet Use in Hallux Valgus Surgery | 2026-11 |
| NCT07653828GCS Ramsay Santé pour l'Enseignement et la RechercheEvaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected Application | 2026-12 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Hallux Valgus with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To assess the average whole body radiation dose received by the surgeon, the operating team and the patient during hallux valgus surgery, depending on whether the surgery is percutaneous or conventional.
Prospective, open, comparative, non-randomized, non-interventional, single-center study, focusing on two surgical strategies. Patients will be managed in accordance with current practice, the choice of surgical strategy being left to the discretion of the investigators.
Patients will be informed of the study during a preoperative visit. The data concerning them will be collected on the day of the surgery. No follow-up over time is necessary.
Passive "ring" and "cornea" dosimeters will be worn by healthcare professionals during procedures for patients included in the study. Their data will be collected each month and at the end of the study, and reported secondarily to the number of operations. Several surgeons, dressers and operating assistants will participate in the operations, their data will be aggregated taking into account their function and not individuals.
Patients will be managed in accordance with current practice, the choice of surgical strategy for hallus valgus (percutaneous or conventional) being left to the discretion of the investigators.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient will have a percutaneous hallus valgus surgery
Radiation: Irradiation collected at the end of the operation on the active dosimeter
Patient will have a conventional hallus valgus surgery
Radiation: Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team
Irradiation collected at the end of the operation on the surgeon's active dosimeter
Measure of irradiation in mSv by a dosimeter
Time frame: during the time of the surgery
Irradiation collected at the end of the operation on the surgeon's active dosimeter
Measure of irradiation in mGy.cm² by a dosimeter
Time frame: during the time of the surgery
Irradiation collected at the end of the operation on the patient's and operating team's
Measure of irradiation in mSv by a dosimeter
Time frame: during the time of the surgery
Irradiation collected at the end of the operation on the patient's and operating team's
Measure of irradiation in mGy.cm² by a dosimeter
Time frame: during the time of the surgery
Irradiation collected on the passive "ring" and "cornea" dosimeters of each health professional
Measure of irradiation in mSv by a dosimeter
Time frame: 3 months
Irradiation collected on the passive "ring" and "cornea" dosimeters of each health professional
Measure of irradiation in mGy.cm² by a dosimeter
Time frame: 3 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2022 to primary completion in Apr 2023, 15 months.
Of 15 observational studies under Hallux Valgus, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 62. This study's 15 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GCS Ramsay Santé pour l'Enseignement et la Recherche →